湘財股份(600095.SH):就轉讓臨港置業52.86%股權 已完成相關工商變更登記手續
格隆匯 12 月 11日丨湘財股份(600095.SH)公佈,公司於2020年12月8日披露了《關於出售控股子公司股權暨關聯交易的公告》,擬向杭州金林投資管理合夥企業(有限合夥)(“杭州金林”)轉讓公司持有的青島臨港置業有限公司(“臨港置業”)全部52.86%的股權。
公司於近日召開第九屆董事會第九次會議,審議通過了《關於出售青島臨港置業有限公司股權暨關聯交易的議案》,並與杭州金林正式簽署了《股權轉讓協議》。
2020年12月10日,臨港置業辦理完成相關工商變更登記手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.